Ignite Creation Date:
2024-05-06 @ 10:03 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03157167
Status:
COMPLETED
Last Update Posted:
2020-07-16
First Post:
2017-05-04
Brief Title:
An Evaluation of Tc 99m Tilmanocept by Intravenous IV and Subcutaneous SC Injection in Kaposi Sarcoma KS
Sponsor:
Navidea Biopharmaceuticals
Organization:
Navidea Biopharmaceuticals
Organization Data
Organization:
Navidea Biopharmaceuticals
Class:
INDUSTRY
Study ID:
NAV3-24
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Navidea Biopharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| National Institutes of Health NIH | NIH |